Insulet主要从事胰岛素管理系统(OmniPod系统)的开发，制造和销售。OmniPod系统是胰岛素输注系统，用于治疗患有胰岛素依赖型糖尿病。 声明：证券时报力求信息真实、准确，文章提及内容仅供参考，不构成实质性投资建议，据此操作风险自担 下载“证券时报”官方 ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced the Omnipod 5 Automated Insulin Delivery System is now ...

Insulet Corporation PODD recently made its Omnipod 5 automated insulin delivery system commercially available in five more countries, Italy, Denmark, Finland, Norway and Sweden. Omnipod 5 is ...

Insulet (PODD) Corporation announced the Omnipod 5 Automated Insulin Delivery System is now commercially available in five more countries-Italy, Denmark, Finland, Norway, and Sweden. Omnipod 5 is ...

The Omnipod 5 Automated Insulin Delivery System is now commercially available in Italy, Denmark, Finland, Norway, and Sweden with Abbott’s FreeStyle Libre 2 Plus and Dexcom G6 ACTON, Mass., January 13 ...

Moreover, a 26.4% year-over-year growth in Insulet’s Omnipod revenues led to a notable 25.7% annual rise in its top-line figure. A 353-bps operating margin expansion and a 155-bps gross margin ...

(Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the fourth quarter ...